MUMBAI: Sun Pharmaceutical has launched generic Amifostine for injection 500mg, which is therapeutically equivalent to Medlmmune's Ethyol.

The company received USFDA approval earlier in March. The product is being sold in US by its marketing partner Caraco Pharmaceutical Laboratories.

Ethyol has annual sales of $80 million in US.
Sun Pharma, being the first-to-file an ANDA for generic Ethyol, has a 180-day marketing exclusivity. 
 
Drug licensing authority held at Baddi

 pharma news, pharma portal , site , industries , news india ,news hindi , most popular site , trade ,medical india ,media , newspaper ,tablet , directory , pharma brand , pharma pormotion , advertisement ,pharma planing , business, pharmabiz , drug news , capsule news ,injection ,trade india ,formulation , drugscontrol , drugs company news, health today india, health today,healthtodayindia, medical portal,medical news,health news,pharma scheme,company offers,pharma newspaper,health today hisar,health today newspaper,medico matromonial,medical rep,chemist ,ban drugs,sting operation, rti haryana,medical india ,drug controller